Page 1917 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1917

1344        Index


                 Intensive care unit (ICU) (Cont.):    promoting sleep in, 161           Intensive care unit staffing, 15–22
                   hazard vulnerability analysis (HVA) and,   providing palliative care in, 121–123,    hospitalists, 17
                        57–58, 58t                          121f, 124t                     house officers, 17
                   implementing critical care curriculum, 5, 5t  renal replacement therapy in, 932  intensivists, 16
                   infection prevention and surveillance in  defined, 933                  pharmacists, 21–22
                     infection prevention policies and   dose of therapy, 938–939, 940t    respiratory therapists, 21–22
                        procedures, 24                   future directions, 942–943        telemedicine, 17
                     nursing staffing ratios, 24         indications for and timing of initiation,   Intensives, nighttime availability of, 12
                     structural/organizational factors that   933–934, 933t, 935t        Intensivists, 3
                        affect infection prevention, 24  modality of                       around-the-clock presence of, 16
                   infection prevention policies and       acid-base disturbance, 937      open versus closed intensive care units and
                                https://kat.cr/user/tahir99/
                        procedures in, 24                  acute liver failure, 936–937         related topics, 16
                   integration of, into hospital and community   acute-neurologic injury, 937  in regionalization, 64
                        emergency planning, 59–61, 60f, 62f  diffusive versus convective   role of, in telemedicine, 68
                   International Classification of Disease    therapies, 938               workload of, 16
                        (ICD) issues in, 293               hyperphosphatemia, 937        Interactive care, 64
                   interventions to prevent health-care    intermittent versus continuous   Interleukin-1 inhibition, use of, in critically ill
                        associated infections, 26           delivery, 934–936                   patient, 1252
                   intravascular devices in, 179–186       severe sepsis, 937–938        Interleukin-1 receptor-associated kinase
                     central internal jugular approach, 180, 181f  supportive care              (IRAK), 552
                     infectious complications of central   medication dosing, 942        Interleukin-6 (IL-6), sepsis and, 567
                        venous catheters, 182–183          nutritional support, 941–942  Interleukin-6 inhibition, use of, in critically ill
                     infraclavicular subclavian approach, 180  technical aspects                patient, 1252
                     placement of central venous catheters, 180  access, 939–940         International Classification of Disease (ICD)
                     posterior internal jugular approach,    anticoagulation, 940–941           issues, in intensive-care unit
                        180, 181f                      role of palliative care in, 120–121      setting, 293
                     ultrasound-guided placement, 180  roots of, 2                       International Classification of Functioning,
                   invasive devices and ICU-acquired   safety scorecard in quality              Disability, and Health (ICF),
                        infections, 24–26                   improvement, 36–37                  109–110, 110f
                     arterial catheters and pressure   seizures in, 779–786              International League Against
                        transducers, 25                  classification of, 780–781             Epilepsy’s (ILAE) classification
                     central venous catheters/pulmonary   clinical manifestations, 781–782      of seizures, 780
                        arterial catheters, 24–25, 24t   diagnostic approach, 782–783    International Standards Organization (ISO),
                     intracranial pressure-monitoring    epidemiology and outcome, 779–780, 779t  defining quality, 7
                        devices, 26                      management approach, 783–786, 783t, 785t  Interoperability, standards for, 53–54
                     respiratory therapy equipment and   pathogenesis and pathophysiology, 781  Interpretation of rheumatology laboratory
                        nasogastric tubes, 25–26, 26t  sleep after, 161                         abnormalities, 1247–1250
                     urinary catheters, 25, 25t        structural/organizational factors that affect   Interstitial edema, 794
                   management of patient with acute abdomen,   infection prevention, 24  Interstitial pulmonary fibrosis, 1090
                        1079–1083, 1079t, 1081t, 1082f  supportive care for AIDS patients in,    Interventional clinical studies in glycemic
                   managing death and dying in, 3–5, 4t     641–642, 642f                       control, 143–144, 143t, 144t
                   “meaningful use” of HIT in, 53–55, 54ft  ultrasonography in, 202–208  Interventional lung assist, 471
                   models of care in, 12                 applications of critical care   Interventional management, 304–305, 305f
                   monitoring renal function in, 922–923, 923f  ultrasonography, 203–205  Interventional radiology, 209
                   occupational health and, 30           cardiac ultrasonography, 206–208  Interventions
                   open, 16                              equipment requirements, 203       encouraging independent interpreting of, 5
                   practical implementation of an exercise   scope of practice and training in critical   liberating from, 2–3
                        and mobilization program in acute   care ultrasonography, 202–203  to prevent health care-associated infections
                        care, 165–166                    thoracic ultrasonography, lung and     in intensive-care unit, 26
                   preventing antibiotic resistance in      pleura, 205–206              Intestinal injuries, 1163–1164
                     hand hygiene, 28                Intensive care unit-acquired weakness,    Intestinal ischemia, pathophysiology
                     surveillance, 27–28                    763–770, 764f                       of, 1038
                     use and control, 27–28            adjunctive testing for neuromuscular  Intestinal obstruction, 1004–1006,
                   preventing morbidity in, 32–37, 33f, 35f, 36f  injury, 766–769, 767f, 768t   1004t, 1005t
                     integrated approach to patient safety, 36  clinical presentation, 765, 765t  workup of bowel, 1005
                     Meningococcus, 31                 critical care survivorship, 764–765  Intra-abdominal candidiasis, 649
                     preventable versus inevitable harm in, 32  differential diagnosis of, 765, 766t  Intra-abdominal infection, 645
                     safety and, 32–33, 33t            prevention and treatment of, 769–770  Intra-aortic balloon pump (IABP),
                     safety scorecard, 36–37         Intensive-care unit (ICU) nurses, special   298, 307
                     science of safety, 32–33, 33t          critical care certification, 21  Intra-arterial disease, 976
                     taxonomy of patient safety issues,    Intensive care unit (ICU) patients  Intracerebral hemorrhage, 775, 776t
                        33–36, 34t, 35f                etiology of thrombocytopenia in, 849–853,   Intracranial bleeding, 1128
                   preventing transmission of pathogens between   850t, 851t             Intracranial hemorrhage, 876–877,
                        patients and personnel, 28–30, 29t  evaluation of acute abdominal pain in,   876t
                   principles of medical informatics and    1078–1079, 1078ft            Intracranial hypertension, treatment of,
                        clinical informatics in, 49–55, 50f,   frequency and general risk factors for   1132–1135
                        51ft, 53f, 54ft                     bleeding in, 845–846         Intracranial mycotic aneurysm, 687







            Index.indd   1344                                                                                           23-01-2015   15:33:52
   1912   1913   1914   1915   1916   1917   1918   1919   1920   1921   1922